KIDS — Orthopediatrics Cashflow Statement
0.000.00%
- $534.87m
- $539.15m
- $204.73m
- 67
- 47
- 32
- 46
Annual cashflow statement for Orthopediatrics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -32.9 | -16.3 | 1.26 | -21 | -37.8 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 12.1 | 6.2 | -13.3 | 9.9 | 19.4 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.99 | -12.6 | -17.8 | -32.2 | -22.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -18.5 | -13.1 | -21.8 | -27 | -27 |
Capital Expenditures | -11.3 | -16 | -10 | -19 | -14.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -58.4 | 8.6 | -103 | 60.7 | 1.75 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -69.7 | -7.41 | -113 | 41.7 | -13.2 |
Financing Cash Flow Items | — | — | -3.23 | -2 | -8.02 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 46.7 | 0.006 | 136 | 7.3 | 53.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -41.9 | -21.1 | 1.46 | 22.6 | 12.8 |